Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria - Wikidata - wikimedia - TriplyDB

Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria

Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria

http://www.wikidata.org/entity/Q35112348

about

Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia Occurrence of pfatpase6 Single Nucleotide Polymorphisms Associated with Artemisinin Resistance among Field Isolates of Plasmodium falciparum in North-Eastern Tanzania Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria The role of early detection and treatment in malaria elimination Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization Malaria: progress, perils, and prospects for eradication Plasmodium falciparum drug resistance in Angola Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression PfMDR1: mechanisms of transport modulation by functional polymorphisms Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure In vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genes In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia Nonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparum Measuring Patient Adherence to Malaria Treatment: A Comparison of Results from Self-Report and a Customised Electronic Monitoring Device Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia Molecular surveillance as monitoring tool for drug-resistant Plasmodium falciparum in Suriname.Increased pfmdr1 copy number in Plasmodium falciparum isolates from Suriname.World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite.Experimental evolution, genetic analysis and genome re-sequencing reveal the mutation conferring artemisinin resistance in an isogenic lineage of malaria parasites.Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.Treatment with coartem (artemether-lumefantrine) in Papua New Guinea Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates Adherence to artemether-lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania.Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.Transporters involved in resistance to antimalarial drugs.Analysis of polymorphisms in Plasmodium falciparum genes related to drug resistance: a survey over four decades under different treatment policies in Brazil.Artemether-lumefantrine: an option for malaria.

P2860

Q21034146-DD9FE09B-65F8-4B45-90D5-57E38CABADFD Q21284494-EBBD15C2-D6CF-4629-B1F5-F73C76E93492 Q24614989-F313B8AB-E827-43C8-963E-EC7996CEB0DB Q26740068-411B2F67-B726-4E25-877A-6C13CC5DA514 Q26783646-CB487E5A-5172-4CBE-A09A-8166C7917D89 Q26830528-F1BD8951-F28A-47E2-A6DB-0B10CCC1B88B Q27485634-4203CBD3-5EC5-458D-AB68-C24C5840207D Q28075079-6F3DC9ED-0973-4E19-8261-B88FC3C68BB6 Q28125914-1A813C48-CFF3-4B65-9684-F625D7EAE765 Q28472222-309ACDF6-0DFD-4C4D-A62C-0D1AED49F8B7 Q28474447-1FA040AD-0C13-4327-8ACE-FF99A9DEFC13 Q28475290-57978483-527D-4019-A203-258D576C91DC Q28476753-D5356139-8ADA-4258-B4A4-A23793A4351A Q28478286-6FAB6A19-D450-4644-935C-C37B37148489 Q28481274-230DEBDA-FC1D-4DC0-AF79-8E0EFA6399FB Q28484068-451ABD48-1F92-4A40-85F2-E423650D2413 Q28533253-AA861C21-B89E-40C5-B67D-DDDA1D68E25F Q28534820-6822D1C5-E8A3-4C6C-9CC1-67447AF0A10C Q28546804-375088D6-3B61-4B70-9155-C64593A1E699 Q28553013-4DFBB492-1F5B-4E02-B1B8-F1B2FA49E34B Q29353745-A4879A10-1B2B-460F-8407-7B8983EAE116 Q29353751-D2AB2664-78FC-438D-AF26-48B28E901209 Q30483555-A34DD61C-187F-4BB8-9E8B-31D4AA57B5AC Q30568502-F72B9FAA-8E5E-4D95-9956-27AC35F16480 Q33298467-7A6868CE-262D-46B1-808E-4009BFC53ABC Q33371043-589B8680-721F-4057-9807-F37D00176BCE Q33385477-4522E931-5C6C-4F09-9574-FF0E5AD1ECE8 Q33559051-E8D6435C-1EC2-4AFB-B903-1E576425062A Q33640021-0EEFE4A6-131D-4777-B491-34F4F685CEC3 Q33693947-0EF129AD-9F5F-4EE8-AB74-57610B6AB80A Q33721915-A3E8574E-852D-4066-B84E-60672B49A80F Q33723453-55D5C453-45F2-4253-A93A-8F0BF7092A94 Q33749688-917F3E1D-F31B-4891-A58A-CA38C0857763 Q33752129-63A81C2F-88DD-49A7-B58D-65688C1D8F8F Q33928184-D43010FC-66B6-44A1-921B-12AF48A91D6A Q34058351-FF46946B-9CAE-462F-8726-76F9DF449900 Q34068703-EAACF741-9576-4AE5-985B-07C2734F4B7C Q34151405-BC9C7FC4-A723-4465-990A-39A134DA4E9C Q34256119-E1137E97-2218-40FE-A900-C81E8B1A83D3 Q34267667-B31004A0-228F-468E-9B92-17C6FA94E028

P2860

Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria

http://www.wikidata.org/entity/Q35112348

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Molecular and pharmacological ...... Plasmodium falciparum malaria

@ast

Molecular and pharmacological ...... Plasmodium falciparum malaria

@en

type

label

Molecular and pharmacological ...... Plasmodium falciparum malaria

@ast

Molecular and pharmacological ...... Plasmodium falciparum malaria

@en

prefLabel

Molecular and pharmacological ...... Plasmodium falciparum malaria

@ast

Molecular and pharmacological ...... Plasmodium falciparum malaria

@en

P1433

Q35112348-E03E6D61-6B3A-4386-AB00-77E1F5F28B0F

P1476

Q35112348-74173F0B-2FF9-4EC3-BA75-8ECAD12FB5DE

P2093

Q35112348-0B09AAF2-0854-4914-8055-C74B079A8A50

Q35112348-194F6EE5-6482-4385-A116-5D76BED35F30

Q35112348-5090A658-BCD0-4C06-9F21-19F94203E02A

Q35112348-73A36D8B-0FF1-4A4D-9AF6-B8F9307244A8

Q35112348-87B2F6BF-A7E7-4027-82F0-05B2A6B2D40A

Q35112348-C74E7D02-6D05-4A67-A727-20930DBA954E

Q35112348-E858A491-BD9A-4AAB-A63C-72606931825A

P2860

Q35112348-002B5EF6-0E27-4651-9353-C458A1A57CE1

Q35112348-044A42B9-BEA6-46D8-AC2D-0013B30A954A

Q35112348-0534EC13-1FFC-447A-97E8-EE119A157A60

Q35112348-08F8C85E-26B3-4055-A7FC-07272599BE96

Q35112348-14E889F4-4116-44B1-9E88-CDE70B06CC6A

Q35112348-19A01C27-E8D0-4810-8A16-7F618ED848AC

Q35112348-1A53A982-F91D-4B47-A402-306FCBE48C8C

Q35112348-1B98D52C-AEA7-4E62-9E47-A178585D1544

Q35112348-1DCE44BB-D1D9-469D-9ECB-A9C82221206A

Q35112348-273CA538-81FA-400F-B685-EE9EB2BF5EDE

P304

Q35112348-D003A4F3-CB37-4B92-82B9-60C31A6B63B9

P31

Q35112348-C88D5A9D-D144-4477-95C4-B22036FA03B1

P356

Q35112348-C58ED091-CED8-424E-9949-3C1ACFB771B5

P407

Q35112348-8AD4D554-CF43-4EA3-9140-ABF1A36CD44C

P433

Q35112348-64250478-0F36-4E47-986D-0F74253DD2D2

P478

Q35112348-FAD3394E-AE7C-4D79-9E87-36210058E7C9

P50

Q35112348-2E580840-1E05-421E-8881-C89225A43C82

Q35112348-37751458-FF7E-40B0-BCEA-5B59B6C5854F

Q35112348-74829BB7-A378-4919-8EAF-42321AB08329

Q35112348-DF0D7558-C6D3-4157-A2B4-A06EEF5D914E

Q35112348-F5AFCF92-0781-4096-AC1A-AF67AE2C4E99

P577

Q35112348-91E1EBA7-295D-4D84-960A-A2B33E2E67AD

P5875

Q35112348-7F094719-C0C5-4198-8C63-0B6BFE9A24D7

P698

Q35112348-073F9017-4B5B-467C-91B9-988EE5F48D09

P921

Q35112348-639C8575-8C75-4F04-8764-75DCCC826356

Q35112348-6AE5E863-E8BE-4262-9400-3BD10D590A9E

Q35112348-7D64427F-FDD9-476D-A0F7-2E50EF46131A

Q35112348-8C981828-7DA1-4706-895B-218CAA94F270

P932

Q35112348-08F6BBD9-2E5C-42D5-964B-0BA03596224A

P356

P1433

Clinical Infectious Diseases

P1476

Molecular and pharmacological ...... Plasmodium falciparum malaria

@en

P2093

Al Brockman

http://www.w3.org/2001/XMLSchema#string

Anne-Catrin Uhlemann

http://www.w3.org/2001/XMLSchema#string

Denae Nash

http://www.w3.org/2001/XMLSchema#string

Michele van Vugt

http://www.w3.org/2001/XMLSchema#string

Ric N Price

http://www.w3.org/2001/XMLSchema#string

Robert Hutagalung

http://www.w3.org/2001/XMLSchema#string

Tim J C Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

Drug resistant falciparum malaria: clinical consequences and strategies for prevention.

Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.

Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.

P304

1570-1577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/503423

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas John White

François H Nosten

Sanjeev Krishna

Pratap Singhasivanon

P577

2006-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7129814

http://www.w3.org/2001/XMLSchema#string

P698

16652314

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

multiple drug resistance

P932

4337983

http://www.w3.org/2001/XMLSchema#string